U.S. Securities and Exchange Commission
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
July 10, 2012 (July 9, 2012)
Date of Report (Date of earliest event Reported)
MESA LABORATORIES, INC.
(Exact Name of Small Business Issuer as Specified in its Charter)
Commission File Number: 0-11740
|
COLORADO |
|
84-0872291 |
|
(State or other Jurisdiction of |
|
(I.R.S. Employer |
|
|
|
|
|
12100 WEST SIXTH AVENUE, LAKEWOOD, |
|
80228 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Issuer’s telephone number, including area code: (303) 987-8000
Not Applicable.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.
On July 9, 2012, Mr. Michael Tranmer resigned from his position and responsibilities as Executive Vice President of Operations — Biological Indicators, for personal reasons, effective immediately.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
MESA LABORATORIES, INC. (Issuer) |
|
|
|
|
DATED: July 10, 2012 |
|
BY: |
/s/ John J. Sullivan |
|
|
|
|
John J. Sullivan, Ph.D. |